SEC Form 4 · accession 0001104659-15-049614
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Michael Cashman
Officer — President and CEO · Director
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2015 | M | 14,086 | $1.04 | A | 112,524 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $1.04 | Jul 1, 2015 | M | 14,086 | D | — | Apr 4, 2023 | Common Stock | 14,086 | 56,346 | D |
Explanation of responses
- F117,596 shares vested on 04/04/2013; remaining shares vest in 43 equal monthly installments